(Q33709227)

28 July 2017

1 reference

title

Antidepressants for the new millennium (English)

1 reference

28 July 2017

Skolnick P

1

1 reference

PubMed ID

10443562

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

European Journal of Pharmacology

28 July 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 July 2017

375

1 reference

28 July 2017

31-40

1 reference

28 July 2017

1-3

1 reference

Neurotrophins and depression

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Transsynaptic control of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Modulation of N-methyl-D-aspartate receptor function by glycine transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

The antidepressant metapramine is a low-affinity antagonist at N-methyl-D-aspartic acid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Is the forced swimming test a suitable model for revealing antidepressant activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

1-Aminocyclopropanecarboxylic acid: mouse to man interspecies pharmacokinetic comparisons and allometric relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Glutamate neurotoxicity and diseases of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Ethanol inhibits NMDA-induced increases in free intracellular Ca2+ in dissociated brain cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

A molecular and cellular theory of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

PDE 4 inhibitors: the use of molecular cloning in the design and development of novel drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Regulation of alternative splicing of NMDAR1 in the kindling model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Effects of MK-801 and antidepressant drugs in the forced swimming test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Efficacy of papaverine addition for treatment-refractory major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Potential antidepressive properties of amantadine, memantine and bifemelane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Repeated ECS induces GluR1 mRNA but not NMDAR1A-G mRNA in the rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

The prevalence of depressive disorders in the United Kingdom.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Brain-derived neurotrophic factor (BDNF) protects cultured rat cerebellar granule neurons against glucose deprivation-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Regulation of transcription by MAP kinase cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT1A serotonin receptors in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

1-Aminocyclopropane-carboxylic acid reduces NMDA-induced hippocampal neurodegeneration in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900330-1

10.1016/S0014-2999(99)00330-1

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10443562